Table 4:
Initial posttreatment versus subsequent follow-up
Combined Primary and Nodes
Posttreatment
Follow-Up
NI-RADS 1
5.7% (5/88)
3.4% (15/440)
NI-RADS 2
20.0% (4/20)
15.8% (6/38)
NI-RADS 3
50.0% (4/8)
62.5% (15/24)
Combined, all categories
11.2% (13/116)
7.2% (36/502)